prat@ab-biotics.com

For World Microbiome Day, let’s talk about gut dysbiosis and its detrimental impact in human health.

We are thrilled to announce that our two finalists, AB21® and LipiGO®, have both taken home the crown in their respective categories for this year’s NutraIngredients Awards

AB-BIOTICS acquired Pharma GMP and Probiotics production facility Alifarm, (Llicè de Vall, Barcelona) to further develop its Probiotics packaging solutions for their customers.

AB-BIOTICS releases 2021 financial accounts and General Shareholders Meeting information, Barcelona, at May 5th 2022, AB-BIOTICS has posted call notice

Frontiers has published the latest clinical data of AB-KOLICARE™, that shows quite promising results on infant colic. This probiotic formulation leads AB-BIOTICS pediatric line, containing two bacteria strains with a battery of benefits for babies.

A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.

A newly published clinical trial in Gut Microbes – a top journal reporting the latest science in microbiota – has confirmed that Kaneka Group / AB-Biotics’ AB21 probiotic formulation exhibits significant positive effects in COVID-19 outpatients.

To offer a preventive, natural solution to Filipinos in risk of high cholesterol, Pharex and AB-BIOTICS have recently launched Biome Lipidec.

AB-LIFE probiotic formulation has recently been approved by the Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária, Anvisa) as a safe and efficient food supplement to help reduce cholesterol levels.